

The Latest
-
The Myth of the “Perfect Pet Parent”—Why Showing Up Is More Than Enough
Pet ownership is rarely perfect, and that’s perfectly okay.
Promoted By Hill's Pet Nutrition -
Maye Watch: Patriots QB develops connection with TreVeyon Henderson
Patriots quarterback Drake Maye looked to running back TreVeyon Henderson in a key spot during Tuesday’s practice.
-
Patriots stock watch: Stefon Diggs looking more involved as season nears
Stefon Diggs was more involved when the Patriots held their final practice before their preseason finale vs. Giants, writes Phil Perry.
-
Pop Mart, home of Labubu, is coming to the Natick Mall
Pop Mart, the brand behind the popular Labubu dolls, is opening its first Massachusetts location at the Natick Mall.
-
MAPS: Track Hurricane Erin as storm moves toward New England coast
Hurricane Erin is moving up the Atlantic Ocean off the East Coast as of Wednesday afternoon. Its current direction is aimed for Boston, but its track will take it curling away, out to sea.
-
Fire that destroyed Reading home and barn was intentionally set, officials say
A July fire that destroyed a home and a historic barn in Reading, Massachusetts, appears to have been intentionally set, fire investigators said.
-
Does Efton Chism remind Julian Edelman of himself? Patriots legend weighs in
Patriots legend Julian Edelman discussed Efton Chism III when he appeared on the Patriots Talk podcast.
-
How much do you need to make in Greater Boston to buy a home?
As anyone who’s bought — or tried to buy — a home in the Boston area lately can attest, it can take a lot of money to afford a place around here.
-
Developer behind high-profile projects files for bankruptcy
The owner of a Wellesley-based firm behind a number of major developments in central Massachusetts and others in Boston has filed for Chapter 7 bankruptcy.
-
After culling 90% of staff, Waltham biotech finds buyer
Mural Oncology plc experienced a major setback earlier this year with its lead cancer treatment, resulting in widespread layoffs and setting the stage for a forthcoming deal for the embattled biotech.